Literature DB >> 24683718

The heavy chain diseases: clinical and pathologic features.

Giada Bianchi, Kenneth C Anderson, Nancy Lee Harris, Aliyah R Sohani.   

Abstract

Heavy chain diseases are a family of rare, systemic syndromes typically associated with or representing a variant of a B-cell neoplasm. Their characteristic feature is production of a mutated immunoglobulin heavy chain incapable of either partnering with light chains in the formation of a full immunoglobulin molecule or of being degraded by the proteasome. The abnormal heavy chain is detected in urine and/or serum without an associated light chain, a pathognomonic finding. Depending on the subtype of the altered heavy chain, these conditions can be subclassified as alpha, gamma, or mu heavy chain disease. We discuss the clinical presentation; epidemiology; laboratory, radiologic, and pathologic features; and treatment options for each of the heavy chain diseases, emphasising the importance of an accurate pathologic diagnosis and correct interpretation of immunologic studies in their identification.

Mesh:

Year:  2014        PMID: 24683718

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  7 in total

Review 1.  Heavy Chain Disease of the Small Bowel.

Authors:  Giada Bianchi; Aliyah R Sohani
Journal:  Curr Gastroenterol Rep       Date:  2018-01-25

2.  T cell receptor rearrangements in a patient with γ-heavy chain disease: A case report.

Authors:  Hebing Zhou; Wenming Chen; Juan Zhang; Hui Zeng; Yuan Jian; Chenxiao Fu
Journal:  Oncol Lett       Date:  2016-05-04       Impact factor: 2.967

3.  AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.

Authors:  Shun Manabe; Chihiro Iwasaki; Michiyasu Hatano; Fuyuki Kametani; Masahide Yazaki; Kosaku Nitta; Michio Nagata
Journal:  BMC Nephrol       Date:  2018-11-22       Impact factor: 2.388

4.  Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.

Authors:  Sho Shibata; Akiko Fukunaga
Journal:  BMJ Case Rep       Date:  2020-11-30

5.  Immunoproliferative Small Intestinal Disease Diagnosed by Double-balloon Endoscopy with Biopsy Sampling.

Authors:  Miguel Ricardo Rodríguez Meza; Masanao Nakamura; Takeshi Yamamura; Keiko Maeda; Tsunaki Sawada; Eri Ishikawa; Naomi Kakushima; Kazuhiro Furukawa; Eizaburo Ohno; Takashi Honda; Hiroki Kawashima; Masatoshi Ishigami
Journal:  Intern Med       Date:  2022-02-08       Impact factor: 1.282

6.  Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.

Authors:  Starlynn C Clarke; Biao Ma; Nathan D Trinklein; Ute Schellenberger; Michael J Osborn; Laure-Hélène Ouisse; Andrew Boudreau; Laura M Davison; Katherine E Harris; Harshad S Ugamraj; Aarti Balasubramani; Kevin H Dang; Brett Jorgensen; Heather Anne N Ogana; Duy T Pham; Payal P Pratap; Preethi Sankaran; Ignacio Anegon; Wim C van Schooten; Marianne Brüggemann; Roland Buelow; Shelley Force Aldred
Journal:  Front Immunol       Date:  2019-01-07       Impact factor: 7.561

Review 7.  Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era.

Authors:  Eri Ishikawa; Masanao Nakamura; Akira Satou; Kazuyuki Shimada; Shotaro Nakamura
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.